Fractyl Health, Inc. Common Stock
Fractyl Health, Inc. Common Stock (GUTS) Revenue
Annual & quarterly revenue history · segment & region breakdown
GUTS · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsFractyl Health, Inc. Common Stock trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.
Revenue trend
– · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Fractyl Health, Inc. Common Stock receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Fractyl Health, Inc. Common Stock reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Fractyl Health, Inc. Common Stock's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
GUTS revenue · 4 questionsGUTS's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.
▸ Source: FMP · Fractyl Health, Inc. Common Stock SEC filings · GAAP · Fractyl Health, Inc. Common Stock SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026